Skip to main content
. 2016 Jul 12;19(3):258–263. doi: 10.1038/pcan.2016.7

Table 1. PROMIS inclusion and exclusion criteria.

Patient inclusion criteria
 Men at least 18 years or over at risk of prostate cancer who have been advised to have a prostate biopsy
 Serum PSA ⩽15ng ml−1 within previous 3 months
 Suspected stage ⩽T2 on rectal examination (organ confined)
 Fit for general/spinal anaesthesia
 Fit to undergo all protocol procedures including a transrectal ultrasound
 Signed informed consent
 
Patient exclusion criteria
 Treated using 5-alpha-reductase inhibitors at time of registration or during the prior 6 months
 Previous history of prostate biopsy, prostate surgery or treatment for prostate cancer (interventions for BPH/bladder outflow obstruction are acceptable)
 Evidence of a urinary tract infection or history of acute prostatitis within the last 3 months
 Contraindication to MRI (e.g., claustrophobia, pacemaker, estimated GFR ⩽50)
 Any other medical condition precluding procedures described in the protocol
 Previous history of hip replacement surgery, metallic hip replacement or extensive pelvic orthopaedic metal work.

Abbreviations: GFR, glomerular filtration rate; MRI, magnetic resonance imaging.